Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 4694726, 10 pages
http://dx.doi.org/10.1155/2016/4694726
Research Article

Fish Oil Reduces Hepatic Injury by Maintaining Normal Intestinal Permeability and Microbiota in Chronic Ethanol-Fed Rats

1School of Nutrition and Health Sciences, Taipei Medical University, Taipei 110, Taiwan
2Department of Nutrition and Health Sciences, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan
3National Applied Research Laboratories, National Laboratory Animal Center, Taipei 115, Taiwan

Received 23 December 2015; Revised 8 March 2016; Accepted 28 March 2016

Academic Editor: Helieh Oz

Copyright © 2016 Jiun-Rong Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Das and D. M. Vasudevan, “Alcohol-induced oxidative stress,” Life Sciences, vol. 81, no. 3, pp. 177–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D'Argenio, R. Cariello, C. Tuccillo et al., “Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?” Liver International, vol. 33, no. 5, pp. 687–697, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Criado-Jiménez, L. Rivas-Cabañero, J. A. Martín-Oterino, J. M. López-Novoa, and A. Sánchez-Rodríguez, “Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis,” Journal of Molecular Medicine, vol. 73, no. 1, pp. 31–33, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. N. C. A. Hunt and R. D. Goldin, “Nitric oxide production by monocytes in alcoholic liver disease,” Journal of Hepatology, vol. 14, no. 2-3, pp. 146–150, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. McClain and D. A. Cohen, “Increased tumor necrosis factor production by monocytes in alcoholic hepatitis,” Hepatology, vol. 9, no. 3, pp. 349–351, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Staun-Olsen, M. Bjørneboe, H. Prytz, Å. C. Thomsen, and F. Ørskov, “Escherichia coli antibodies in alcoholic liver disease. Correlation to alcohol consumption, alcoholic hepatitis, and serum iga,” Scandinavian Journal of Gastroenterology, vol. 18, no. 7, pp. 889–896, 1983. View at Publisher · View at Google Scholar · View at Scopus
  7. R. K. Rao, A. Seth, and P. Sheth, “Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 286, no. 6, pp. G881–G884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Keshavarzian, E. W. Holmes, M. Patel, F. Iber, J. Z. Fields, and S. Pethkar, “Leak gut in alcoholic cirrhosis: a possible mechanism for alcoholic-induced liver damage,” American Journal of Gastroenterology, vol. 94, no. 1, pp. 200–207, 1999. View at Publisher · View at Google Scholar
  9. W.-C. Chiu, Y.-L. Huang, Y.-L. Chen et al., “Synbiotics reduce ethanol-induced hepatic steatosis and inflammation by improving intestinal permeability and microbiota in rats,” Food & Function, vol. 6, no. 5, pp. 1692–1700, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. L.-L. Huang, J.-B. Wan, B. Wang et al., “Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 88, no. 5, pp. 347–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Wada, T. Yamazaki, Y. Kawano, S. Miura, and O. Ezaki, “Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice,” Journal of Hepatology, vol. 49, no. 3, pp. 441–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. L. E. M. Willemsen, M. A. Koetsier, M. Balvers, C. Beermann, B. Stahl, and E. A. F. van Tol, “Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro,” European Journal of Nutrition, vol. 47, no. 4, pp. 183–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Liu, H. Hougen, A. C. Vollmer, and S. M. Hiebert, “Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids,” Anaerobe, vol. 18, no. 3, pp. 331–337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ghosh, D. DeCoffe, K. Brown et al., “Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis,” PLoS ONE, vol. 8, no. 2, Article ID e55468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Lieber and L. M. DeCarli, “Animal models of chronic ethanol toxicity,” Methods in Enzymology, vol. 233, pp. 585–594, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Farhadi, A. Keshavarzian, J. Z. Fields, M. Sheikh, and A. Banan, “Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 836, no. 1-2, pp. 63–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” The FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. W. Shin, I. C. Seol, and C. G. Son, “Interpretation of animal dose and human equivalent dose for drug development,” The Journal of Korean Oriental Medicine, vol. 31, no. 3, pp. 1–7, 2010. View at Google Scholar
  19. C. Hézode, I. Lonjon, F. Roudot-Thoraval, J.-M. Pawlotsky, E.-S. Zafrani, and D. Dhumeaux, “Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 8, pp. 1031–1037, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. N. A. Pikaar, M. Wedel, E. J. van der Beek et al., “Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids,” Metabolism, vol. 36, no. 6, pp. 538–543, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. C. S. Lieber, “Hepatic, metabolic and toxic effects of ethanol: 1991 update,” Alcoholism: Clinical and Experimental Research, vol. 15, no. 4, pp. 573–592, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-L. Chen, H.-C. Peng, Y.-C. Hsieh, and S.-C. Yang, “Epidermal growth factor improved alcohol-induced inflammation in rats,” Alcohol, vol. 48, no. 7, pp. 701–706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. W. Huff and D. E. Telford, “Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein,” Arteriosclerosis, vol. 9, no. 6, pp. 58–66, 1989. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Gao, “Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease,” Journal of Gastroenterology and Hepatology, vol. 27, no. 2, pp. 89–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. McClain, S. Barve, I. Deaciuc, M. Kugelmas, and D. Hill, “Cytokines in alcoholic liver disease,” Seminars in Liver Disease, vol. 19, no. 2, pp. 205–219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Bode and J. C. Bode, “Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?” Alcoholism: Clinical and Experimental Research, vol. 29, no. 11, supplement, pp. 166s–171s, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Hoek and J. G. Pastorino, “Ethanol, oxidative stress, and cytokine-induced liver cell injury,” Alcohol, vol. 27, no. 1, pp. 63–68, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. H. A. Järveläinen, “Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines,” Hepatology, vol. 29, no. 5, pp. 1503–1510, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. D. B. Hill, N. B. D'Souza, E. Y. Lee, R. Burikhanov, I. V. Deaciuc, and W. J. S. De Villiers, “A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide,” Alcoholism: Clinical and Experimental Research, vol. 26, no. 1, pp. 74–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Maroon and J. W. Bost, “ω-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain,” Surgical Neurology, vol. 65, no. 4, pp. 326–331, 2006. View at Publisher · View at Google Scholar
  31. V. Purohit, J. C. Bode, C. Bode et al., “Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium,” Alcohol, vol. 42, no. 5, pp. 349–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Li, Q. Zhang, M. Wang, S. Zhao, G. Xu, and J. Li, “n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines,” Molecular Immunology, vol. 45, no. 5, pp. 1356–1365, 2008. View at Publisher · View at Google Scholar · View at Scopus